PHARM.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Earnings surprises

Beat consensus in 2 of the last 2 reported quarters

Reported	Est. EPS	Actual	Surprise
2022-05-11	$-1.09	$-0.77	+29.4%
2022-02-24	$-0.92	$-0.71	+22.8%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
PHARM.STPharmiva AB (publ)	$0.56	-16.17%	$13M	—
AEGIR.STAegirBio AB (publ)	$0.43	+3.88%	$15M	—
AMNI.STAmniotics AB (publ)	$0.01	+5.88%	$15M	—
CYXO.STCyxone AB (publ)	$0.02	+0.00%	$7M	—
DIABIO.STDiagonal Bio AB (publ)	$0.01	+0.00%	$20M	—
IDOGEN.STIdogen AB (publ)	$0.12	-2.82%	$13M	—
L2S.STLearning 2 Sleep L2S AB (publ)	$0.02	+2.50%	$12M	—

Source: Financial Modeling Prep · peers by sector/industry

Pharmiva AB (publ)

Pharmiva AB (publ), a Swedish company based in Lund, specializes in the research and development of medical products. Its flagship product is Vernivia, an over-the-counter vaginal mousse formulated for the treatment of bacterial vaginosis.

www.pharmiva.com

Employees: 5
IPO / List date: Mar 31, 2021
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds PHARM.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in PHARM.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded PHARM.ST yet.